HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Géraldine Pignot Selected Research
Géraldine Pignot Research Topics
Disease
29
Neoplasms (Cancer)
05/2024 - 10/2009
17
Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 10/2009
13
Carcinoma (Carcinomatosis)
01/2021 - 12/2011
10
Renal Cell Carcinoma (Grawitz Tumor)
09/2023 - 01/2015
7
Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2018
6
Non-Muscle Invasive Bladder Neoplasms
11/2023 - 06/2013
5
Neoplasm Metastasis (Metastasis)
01/2022 - 10/2012
5
Carcinogenesis
10/2020 - 06/2013
4
Kidney Neoplasms (Kidney Cancer)
09/2023 - 01/2011
3
Margins of Excision
05/2019 - 10/2012
1
Infections
10/2022
1
Tertiary Lymphoid Structures
10/2022
1
Postoperative Nausea and Vomiting (PONV)
06/2022
1
Urologic Neoplasms (Urological Cancer)
05/2022
1
Kidney Diseases (Kidney Disease)
05/2022
1
Massive Hepatic Necrosis
01/2022
1
Liver Failure
01/2022
1
Thrombotic Microangiopathies
01/2022
1
Bullous Pemphigoid (Pemphigoid)
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Heart Failure
01/2022
1
Digestive System Diseases
01/2022
1
Liver Abscess
10/2021
1
Abscess
10/2021
1
Sarcopenia
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
01/2021
1
Testicular Neoplasms (Testicular Cancer)
12/2016
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2016
1
Teratoma (Teratoid Tumor)
12/2016
1
Endodermal Sinus Tumor (Endodermal Sinus Tumors)
12/2016
1
Pyelitis
07/2016
1
Intraoperative Complications
01/2016
1
Rare Diseases (Rare Disease)
12/2012
1
Constipation
01/2011
1
Asthenia
01/2011
1
Hypothyroidism
01/2011
Drug/Important Bio-Agent (IBA)
9
Immune Checkpoint Inhibitors
IBA
10/2022 - 11/2018
5
Biomarkers (Surrogate Marker)
IBA
10/2022 - 01/2019
4
Nivolumab
IBA
01/2022 - 11/2018
4
Messenger RNA (mRNA)
IBA
10/2019 - 01/2017
3
pembrolizumab
IBA
10/2022 - 11/2018
3
Proteins (Proteins, Gene)
FDA Link
10/2020 - 01/2017
2
Chemokines
IBA
10/2022 - 01/2019
2
DNA (Deoxyribonucleic Acid)
IBA
05/2022 - 10/2019
2
Ipilimumab
IBA
01/2022 - 11/2018
2
atezolizumab
IBA
01/2019 - 11/2018
2
Ligands
IBA
11/2018 - 01/2017
1
Creatinine
IBA
12/2023
1
Antiemetics
IBA
06/2022
1
Propofol (Diprivan)
FDA Link
Generic
06/2022
1
Opioid Analgesics (Opioids)
IBA
06/2022
1
Tyrosine Kinase Inhibitors
IBA
01/2022
1
Lipase (Acid Lipase)
FDA Link
01/2022
1
Sunitinib (Sutent)
FDA Link
01/2022
1
Antibodies
IBA
11/2021
1
Hormones (Hormone)
IBA
01/2021
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2021
1
Choline (Choline Chloride)
IBA
01/2021
1
Cisplatin (Platino)
FDA Link
Generic
01/2021
1
Interferons
IBA
10/2020
1
fluoromethylcholine
IBA
01/2020
1
NVP-BKM120
IBA
01/2019
1
Circulating Tumor DNA
IBA
01/2019
1
tremelimumab
IBA
11/2018
1
avelumab
IBA
11/2018
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
11/2018
1
durvalumab
IBA
11/2018
1
Androgens
IBA
01/2018
1
Ammonium Chloride (Sal Ammoniac)
FDA Link
07/2016
1
Solutions
IBA
07/2016
1
MicroRNAs (MicroRNA)
IBA
06/2013
1
Thyroid Hormones
IBA
01/2011
Therapy/Procedure
15
Therapeutics
11/2023 - 10/2009
13
Nephrectomy
12/2023 - 02/2014
7
Drug Therapy (Chemotherapy)
11/2023 - 12/2016
7
Immunotherapy
10/2020 - 01/2017
7
Nephroureterectomy
03/2015 - 10/2012
6
Cystectomy
01/2021 - 06/2013
2
Precision Medicine
05/2022 - 12/2015
2
Neoadjuvant Therapy
01/2021 - 06/2013
2
Radiotherapy
01/2021 - 01/2018
2
Prostatectomy (Retropubic Prostatectomy)
07/2020 - 05/2019
2
Castration
02/2018 - 01/2018
2
Adjuvant Chemotherapy
01/2018 - 12/2011
1
Minimally Invasive Surgical Procedures
05/2024
1
Immunomodulation
10/2022
1
Analgesia
06/2022
1
Aftercare (After-Treatment)
05/2022
1
General Anesthesia
10/2021
1
Electrodes (Electrode)
10/2021
1
Pancreatectomy
10/2021
1
Radiofrequency Ablation
10/2021
1
Stents
10/2021
1
Duration of Therapy
01/2020
1
Combined Modality Therapy
01/2018
1
Lymph Node Excision (Lymph Node Dissection)
12/2016
1
Orchiectomy (Orchidectomy)
12/2016
1
Conversion to Open Surgery
01/2016